Literature DB >> 15722617

Puberty and fertility in congenital adrenal hyperplasia.

B J Otten1, M M L Stikkelbroeck, H L Claahsen-van der Grinten, A R M M Hermus.   

Abstract

Congenital adrenal hyperplasia (CAH) is a disorder of adrenal steroid synthesis. The symptoms and signs of CAH depend on the degree of enzyme deficiency; severe salt-wasting (SW) form, less severe simple virilizing (SV) form and mild nonclassic (NC) form. In this paper, puberty and fertility in CAH are discussed. The time of onset of puberty and progress of pubertal development is quite normal, except in NC patients (earlier). Also the age of menarche in CAH girls is normal, but it can depend on the level of therapeutic control. In prepuberty, bone age is advanced. In puberty, peak height velocity is normal but occurs at a younger age and can therefore be considered to be low (compared to healthy early maturers). In puberty there seems to be an increased sensitivity for glucocorticoids leading to growth inhibition. All three above factors can play a role in reducing adult height. Subfertility is frequently found in both female and male CAH patients. In females, the pregnancy rate depends on the severity of 21-hydroxylase deficiency (SW<SV<NC). Adrenal progestagens and androgens are the main cause of disturbed ovarian activity. In addition psychosexual problems (e.g. as a result of genital surgery) are an important factor. In males, the main cause of subfertiltiy is the presence of testicular adrenal rest tumors, which are thought to originate from aberrant adrenal tissue and respond to treatment with glucocorticoids. Although in general fertility is not a paediatric item, in CAH most fertility problems have their origins in childhood years. Therefore prevention of subfertility has to be implemented as a treatment goal in paediatric endocrinology from the start of puberty.

Entities:  

Mesh:

Year:  2005        PMID: 15722617     DOI: 10.1159/000084093

Source DB:  PubMed          Journal:  Endocr Dev        ISSN: 1421-7082


  6 in total

1.  Congenital adrenal hyperplasia: long-term evaluation of feminizing genitoplasty and psychosocial aspects.

Authors:  D K Gupta; Sharma Shilpa; A C Amini; M Gupta; Gautam Aggarwal; Gupta Deepika; Khatri Kamlesh
Journal:  Pediatr Surg Int       Date:  2006-11       Impact factor: 1.827

2.  A novel point mutation in helix 10 of the human glucocorticoid receptor causes generalized glucocorticoid resistance by disrupting the structure of the ligand-binding domain.

Authors:  Nancy Nader; Bert E Bachrach; Darrell E Hurt; Sonia Gajula; Amy Pittman; Rachel Lescher; Tomoshige Kino
Journal:  J Clin Endocrinol Metab       Date:  2010-03-24       Impact factor: 5.958

Review 3.  Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.

Authors:  Krupali Bulsari; Henrik Falhammar
Journal:  Endocrine       Date:  2016-12-07       Impact factor: 3.633

4.  Prenatal testosterone supplementation alters puberty onset, aggressive behavior, and partner preference in adult male rats.

Authors:  Cynthia Dela Cruz; Oduvaldo C M Pereira
Journal:  J Physiol Sci       Date:  2012-01-11       Impact factor: 2.781

5.  Testicular adrenal rest tumours in congenital adrenal hyperplasia.

Authors:  H L Claahsen-van der Grinten; A R M M Hermus; B J Otten
Journal:  Int J Pediatr Endocrinol       Date:  2009-02-26

6.  Health-related quality of life of female patients with congenital adrenal hyperplasia in Malaysia.

Authors:  Ani Amelia Zainuddin; Sonia Regina Grover; Nur Azurah Abdul Ghani; Loo Ling Wu; Rahmah Rasat; Mohd Rizal Abdul Manaf; Khadijah Shamsuddin; Zaleha Abdullah Mahdy
Journal:  Health Qual Life Outcomes       Date:  2020-08-01       Impact factor: 3.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.